These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22374985)

  • 21. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V; Jones AP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B
    Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertonic saline and PEP: is it worth a try?
    O'Malley CA
    Respir Care; 2011 Jun; 56(6):886-7. PubMed ID: 21679498
    [No Abstract]   [Full Text] [Related]  

  • 25. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT
    Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
    J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
    Dentice RL; Elkins MR; Middleton PG; Bishop JR; Wark PA; Dorahy DJ; Harmer CJ; Hu H; Bye PT
    Thorax; 2016 Feb; 71(2):141-7. PubMed ID: 26769016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M;
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertonic saline for cystic fibrosis: worth its salt?
    Goralski JL; Donaldson SH
    Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
    Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ
    BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.
    Deterding RR; Lavange LM; Engels JM; Mathews DW; Coquillette SJ; Brody AS; Millard SP; Ramsey BW;
    Am J Respir Crit Care Med; 2007 Aug; 176(4):362-9. PubMed ID: 17446337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
    Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
    Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertonic saline for cystic fibrosis.
    Aziz I; Kastelik JA
    N Engl J Med; 2006 Apr; 354(17):1848-51; author reply 1848-51. PubMed ID: 16641405
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
    Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
    Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.